You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 10,357,502


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,357,502 protect, and when does it expire?

Patent 10,357,502 protects RAYALDEE and is included in one NDA.

This patent has eighty-one patent family members in thirty-six countries.

Summary for Patent: 10,357,502
Title:Stabilized modified release vitamin D formulation and method of administering same
Abstract: A stabilized formulation for controlled release of a vitamin D compound is disclosed. The formulation comprises one or both of 25-hydroxyvitamin D.sub.2 and 25-hydroxyvitamin D.sub.3 and a cellulosic compound. The stabilized formulations exhibit a stable dissolution profile following exposure to storage conditions and demonstrate improved pharmacokinetic parameters compared to unstabilized formulations.
Inventor(s): White; Jay A. (Newmarket, CA), Tabash; Samir P. (Whitby, CA), Agudoawu; Sammy A. (Mississauga, CA), Melnick; Joel Z. (Miami, FL)
Assignee: OPKO IRELAND GLOBAL HOLDINGS, LTD. (Grand Cayman, KY)
Application Number:15/990,352
Patent Claim Types:
see list of patent claims
Use; Formulation; Compound; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 10,357,502: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the details of United States Patent 10,357,502, using resources from the U.S. Patent and Trademark Office (USPTO) and other relevant datasets.

Understanding Patent 10,357,502

To begin, it is essential to identify the patent in question. United States Patent 10,357,502 can be found using the USPTO's patent search tools, such as the Patent Public Search or the Patent and Trademark Resource Centers (PTRCs)[4].

Patent Title and Abstract

The title and abstract of the patent provide a preliminary understanding of its scope. For example, if the patent is titled "Method and System for [Specific Technology]," the abstract will give a brief overview of the invention, including its purpose, key features, and any novel aspects.

Claims

The claims section is the most critical part of a patent, as it defines the legal scope of the invention. Claims can be independent or dependent and are typically categorized into different types such as method claims, system claims, and apparatus claims.

Independent Claims

Independent claims stand alone and define the invention without reference to other claims. These claims are broad and encompass the core aspects of the invention.

Dependent Claims

Dependent claims refer back to an independent claim and further limit the scope of the invention. They often add specific details or variations to the independent claims.

Claim Analysis Using USPTO Datasets

The USPTO provides several datasets that can be used to analyze patent claims in depth. For instance, the Patent Claims Research Dataset contains detailed information on claims from U.S. patents granted between 1976 and 2014, including claim-level statistics and document-level statistics[3].

Patent Scope and Measurements

The scope of a patent is a critical aspect that determines its breadth and the extent of protection it offers. The USPTO's Office of Chief Economist has developed measures of patent scope, which include various statistical analyses of the claims.

Patent Scope Measurements

The Patent Claims Research Dataset includes newly-developed measures of patent scope, such as the number of claims, claim length, and dependency relationships between claims. These metrics help in understanding the complexity and breadth of the patent[3].

Citation Analysis

Citations made by and to the patent are another important factor in understanding its landscape. The PatentsView database and the USPTO's datasets provide extensive information on citations.

Forward and Backward Citations

Forward citations refer to patents that cite the patent in question, while backward citations refer to patents cited by the patent in question. These citations can indicate the patent's influence and its position within the broader technological landscape[1].

Non-Patent Citations

Non-patent citations, such as articles and papers, mentioned in the patent can also provide insights into the underlying research and technology[1].

International Patent Classification (IPC)

The International Patent Classification (IPC) system helps in categorizing patents based on their technological fields. The IPC data for all patents, including Patent 10,357,502, can be found in the PatentsView database and USPTO datasets[1].

Patent Family and Global Dossier

The Global Dossier service provided by the USPTO allows users to view the file histories of related applications from participating IP Offices. This service helps in understanding the global patent family of the patent and its status in different jurisdictions[4].

Legal and Practical Considerations

Patent Assignment and Ownership

The Patent Assignment Search tool can be used to track changes in ownership of the patent, which is crucial for understanding its current legal status and any potential disputes[4].

Litigation and Enforcement

The study on a small claims patent court by the Administrative Conference of the United States (ACUS) highlights the legal and practical considerations in enforcing patent rights. This includes the feasibility of a small claims court for patent disputes, which could impact how patents like 10,357,502 are enforced[5].

Public Search and Resource Centers

Patent Public Search

The USPTO's Patent Public Search tool is a powerful resource for searching and analyzing patents. It provides enhanced access to prior art and improves the overall patent searching process[4].

Patent and Trademark Resource Centers (PTRCs)

Local PTRCs offer training in patent search techniques and maintain local search resources, which can be invaluable for a detailed analysis of Patent 10,357,502[4].

Key Takeaways

  • Claims Analysis: The claims section of the patent defines its legal scope, with independent claims being broad and dependent claims adding specific details.
  • Patent Scope: Measures such as claim length and dependency relationships help in understanding the breadth and complexity of the patent.
  • Citation Analysis: Forward and backward citations, as well as non-patent citations, provide insights into the patent's influence and technological context.
  • International Classification: IPC data helps in categorizing the patent within its technological field.
  • Global Dossier: This service provides access to the file histories of related applications from participating IP Offices.
  • Legal Considerations: Tracking changes in ownership and understanding potential litigation pathways are crucial for managing patent rights.

FAQs

Q: How can I find detailed information on the claims of Patent 10,357,502?

A: You can use the USPTO's Patent Public Search tool or the Patent Claims Research Dataset to find detailed information on the claims of the patent[3][4].

Q: What is the significance of forward and backward citations in patent analysis?

A: Forward citations indicate patents that cite the patent in question, showing its influence, while backward citations indicate patents cited by the patent, showing its foundation[1].

Q: How can I determine the global patent family of Patent 10,357,502?

A: Use the Global Dossier service provided by the USPTO to view the file histories of related applications from participating IP Offices[4].

Q: What resources are available for training in patent search techniques?

A: Local Patent and Trademark Resource Centers (PTRCs) offer training in patent search techniques and maintain local search resources[4].

Q: How can I track changes in ownership of Patent 10,357,502?

A: Use the Patent Assignment Search tool provided by the USPTO to track changes in ownership of the patent[4].

Sources

  1. PatentsView: Data Download Tables - PatentsView.
  2. USPTO: U.S. Patent and Trademark Office (USPTO) | USAGov.
  3. USPTO: Patent Claims Research Dataset - USPTO.
  4. USPTO: Search for patents - USPTO.
  5. ACUS: U.S. Patent Small Claims Court.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,357,502

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Eirgen RAYALDEE calcifediol CAPSULE, EXTENDED RELEASE;ORAL 208010-001 Jun 17, 2016 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,357,502

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 2968172 ⤷  Subscribe 122021000009 Germany ⤷  Subscribe
European Patent Office 2968172 ⤷  Subscribe 301095 Netherlands ⤷  Subscribe
European Patent Office 2968172 ⤷  Subscribe CA 2021 00005 Denmark ⤷  Subscribe
European Patent Office 2968172 ⤷  Subscribe 132021000000074 Italy ⤷  Subscribe
European Patent Office 2968172 ⤷  Subscribe SPC/GB20/043 United Kingdom ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.